Share ownership InterCure Ltd.

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE 10:24:27 2026-09-09 EDT			5-day change	1st Jan Change
1,637.00 ^ILa	-2.79%		-2.79%	+1.17%

09-08	InterCure Regains Nasdaq Compliance	MT
08-24	InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI

Share class: InterCure Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	11,845,711	7,205,378 ( 60.83 %)	0	60.83 %

Major shareholders: InterCure Ltd.

Name	Stocks	%	Valuation
Alexander Rabinovitch 25.01 %	2,962,512	25.01 %	18 M ILa
Yael Figel 6.951 %	823,389	6.951 %	5 M ILa
Yaron Jacobi 6.425 %	761,083	6.425 %	5 M ILa
IBI Mutual Funds Management (1978) Ltd. 0.8791 %	104,138	0.8791 %	623 213 ILa
Amos Cohen 0.7767 %	92,000	0.7767 %	550 573 ILa
Ayalon Mutual Funds Ltd. 0.4716 %	55,867	0.4716 %	334 336 ILa
Healthcare of Ontario Pension Plan Trust Fund 0.3588 %	42,500	0.3588 %	254 341 ILa
Psagot Mutual Funds Ltd. 0.2626 %	31,110	0.2626 %	186 177 ILa
KSM Mutual Funds Ltd. 0.2132 %	25,255	0.2132 %	151 138 ILa
Citadel Securities GP LLC 0.1822 %	21,583	0.1822 %	129 163 ILa
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	39.17%
Institutional	2.29%
Others	0.62%
Unknown	57.92%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	39.17%
Israel	1.88%
United States	0.67%
Canada	0.36%

Based on 1000 largest holdings

InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.

Employees

285

Sector

Healthcare Facilities & Services

More about the company